PSF-TFE3 oncoprotein in papillary renal cell carcinoma inactivates TFE3 and p53 through cytoplasmic sequestration

Oncogene

Volumn 22, Issue 32, 2003, Pages 5031-5044

  Mathur, Mukul ^a   Das, Sharmistha ^a   Samuels, Herbert H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell transformation; Endosomes; PSF A; PSF TFE3; Renal cell carcinoma; TFE3

Indexed keywords

GREEN FLUORESCENT PROTEIN; HELIX LOOP HELIX PROTEIN; HYBRID PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN P53; PROTEIN PSF; PROTEIN PSF TFE3; PROTEIN TFE3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; SMALL INTERFERING RNA; TFE3 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STRAIN COS1; CELL TRANSFORMATION; CHROMOSOME 1; CHROMOSOME TRANSLOCATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENDOSOME; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PHENOTYPE; PROTEIN LOCALIZATION; WESTERN BLOTTING; X CHROMOSOME; ANIMAL; GENETICS; KIDNEY TUMOR; METABOLISM; PATHOLOGY;

ANIMALIA;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CELL TRANSFORMATION, NEOPLASTIC; COS CELLS; CYTOPLASM; DNA-BINDING PROTEINS; ENDOSOMES; KIDNEY NEOPLASMS; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0042284848     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206643     Document Type: Article

References (46)

1. Afonja A, Raaka BM, Huang A, Das S, Zhao X, Helmer E, Juste D and Samuels HH. (2002). Oncogene, 21, 7850-7860.
2. Akhmedov AT and Lopez BS. (2000). Nucleic Acids Res., 28, 3022-3030.
3. Angelo LS, Talpaz M and Kurzrock R. (2002). Cancer Res., 62, 932-940.
4. Artandi SE, Merrell K, Avitahl N, Wong KK and Calame K. (1995). Nucleic Acids Res., 23, 3865-3871.
5. Beckmann H, Su LK and Kadesch T. (1990). Genes Dev., 4, 167-179.
6. Carter RS, Ordentlich P and Kadesch T. (1997). Mol. Cell. Biol., 17, 18-23.
7. Chanas-Sacre G, Mazy-Servais C, Wattiez R, Pirard S, Rogister B, Patton JG, Belachew S, Malgrange B, Moonen G and Leprince P. (1999). J. Neurosci. Res., 57, 62-73.
8. Clark J, Lu YJ, Sidhar SK, Parker C, Gill S, Smedley D, Hamoudi R, Linehan WM, Shipley J and Cooper CS. (1997). Oncogene, 15, 2233-2239.
9. Dingwall C and Laskey RA. (1991). Trends Biochem. Sci., 16, 478-481.
10. Dye BT and Patton JG. (2001). Exp. Cell Res., 263, 131-144.
11. Fisher DE, Carr CS, Parent LA and Sharp PA. (1991). Genes Dev., 5, 2342-2352.
12. Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG and Lazar MA. (1998). Mol. Cell. Biol., 18, 7185-7191.
13. Glukhova L, Goguel AF, Chudoba I, Angevin E, Pavon C, Terrier-Lacombe MJ, Meddeb M, Escudier B and Bernheim A. (1998). Genes Chromosom Cancer, 22, 171-178.
14. Gozani O, Patton JG and Reed R. (1994). EMBO J., 13, 3356-3367.
15. Hannon GJ. (2002). Nature, 418, 244-251.
16. Heimann P, El Housni H, Ogur G, Weterman MA, Petty EM and Vassart G. (2001). Cancer Res., 61, 4130-4135.
17. Hsueh C, Wang H, Gonzalez-Crussi F, Lin JN, Hung IJ, Yang CP and Jiang TH. (2002). Mod. Pathol., 15, 606-610.
18. Hua X, Liu X, Ansari DO and Lodish HF. (1998). Genes Dev., 12, 3084-3095.
19. Li D, Desai-Yajnik V, Lo E, Schapira M, Abagyan R and Samuels HH. (1999). Mol. Cell. Biol., 19, 7191-7202.
20. Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH and Evans RM. (1998). Nature, 391, 811-814.
21. Mahajan MA, Murray A and Samuels HH. (2002). Mol. Cell. Biol., 22, 6883-6894.
22. Mansky KC, Sulzbacher S, Purdom G, Nelsen L, Hume DA, Rehli M and Ostrowski MC. (2002). J. Leukoc. Biol., 71, 304-310.
23. Massari ME and Murre C. (2000). Mol. Cell. Biol., 20, 429-440.
24. Mathur M, Tucker PW and Samuels HH. (2001). Mol. Cell. Biol., 21, 2298-2311.
25. Moll UM, LaQuaglia M, Benard J and Riou G. (1995). Proc. Natl. Acad. Sci. USA, 92, 4407-4411.
26. Moll UM, Riou G and Levine AJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 7262-7266.
27. Oda H, Nakatsuru Y and Ishikawa T. (1995). Cancer Res., 55, 658-662.
28. Paddison PJ and Hannon GJ. (2002). Cancer Cell, 2, 17-23.
29. Patton JG, Porro EB, Galceran J, Tempst P and Nadal-Ginard B. (1993). Genes Dev., 7, 393-406.
30. Pipas JM and Levine AJ. (2001). Semin. Cancer Biol., 11, 23-30.
31. Qi JS, Desai-Yajnik V, Yuan Y and Samuels HH. (1997). Mol. Cell. Biol., 17, 7195-7207.
32. Qi JS, Yuan Y, Desai-Yajnik V and Samuels HH. (1999). Mol. Cell. Biol., 19, 864-872.
33. Reiter RE, Anglard P, Liu S, Gnarra JR and Linehan WM. (1993). Cancer Res., 53, 3092-3097.
34. Rosenberger U, Lehmann I, Weise C, Franke P, Hucho F and Buchner K. (2002). J. Cell Biochem., 86, 394-402.
35. Sewer MB, Nguyen VQ, Huang CJ, Tucker PW, Kagawa N and Waterman MR. (2002). Endocrinology, 143, 1280-1290.
36. Simon JP, Ivanov IE, Adesnik M and Sabatini DD. (2000). Methods, 20, 437-454.
37. Skalsky YM, Ajuh PM, Parker C, Lamond AI, Goodwin G and Cooper CS. (2001). Oncogene, 20, 178-187.
38. Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE and Thompson LM. (2000). Proc. Natl. Acad. Sci. USA, 97, 6763-6768.
39. Steingrimsson E, Tessarollo L, Pathak B, Hou L, Arnheiter H, Copeland NG and Jenkins NA. (2002). Proc. Natl. Acad. Sci. USA, 99, 4477-4482.
40. Tian G, Erman B, Ishii H, Gangopadhyay SS and Sen R. (1999). Mol. Cell. Biol., 19, 2946-2957.
41. Urban RJ and Bodenburg Y. (2002). Am. J. Physiol. Endocrinol. Metab., 283, E794-E798.
42. van den Berg E, Dijkhuizen T, Oosterhuis JW, Geurts van Kessel A, de Jong B and Storkel S. (1997). Cancer Genet. Cytogenet., 95, 103-107.
43. Weterman MA, Wilbrink M and Geurts van Kessel A. (1996). Proc. Natl. Acad. Sci. USA, 93, 15294-15298.
44. Weterman MJ, van Groningen JJ, Jansen A and van Kessel AG. (2000). Oncogene, 19, 69-74.
45. Wu X, Bayle JH, Olson D and Levine AJ. (1993). Genes Dev., 7, 1126-1132.
46. Zhao GQ, Zhao Q, Zhou X, Mattei MG and de Crombrugghe B. (1993). Mol. Cell. Biol., 13, 4505-4512.